Mso Pharma LLC

Johns Hopkins University

Raymond C Koehler

Emad M Boctor

Saul W Brusilow

Richard J Traystman

Jeeun Kang

Maged Harraz

Adarsha Malla

Ernest M Graham

Methods for the treatment of both diseases susceptible to the inhibition of mammalian glutamine synthetase and progressive hyperammonemic encephalopathy comprising administering L-methionine S-sulfoxime at a dose not to exceed 10 mg/kg body weight are disclosed. Preferably, the dose should not exceed 8 mg/kg; more preferably, the dose should not exceed 5 mg/kg; most preferably, the dose should not exceed 2.5 mg/kg.

Dosage form of L-Methionine S-Sulfoximine

Growing community of inventors

Baltimore, MD, United States of America

Raymond C Koehler